Biorbyt Intelligence Profile

biorbyt.comLast reviewed: October 20, 2026Research coverage: 89%

Overall data confidence:Unknown

Identity confidence

High

8 of 10 identity fields independently documented

Corporate continuity

Continuity supported — domain registered 2009-09-09; company trading since 2010/2011 (Queen's Award for Enterprise: International Trade in 2021) and currently operating a large live catalog (1M+ SKUs claimed) with 2026 content and an intact brand post-acquisition

Based on domain history and corporate record fields

Regulatory exposure

None identified

Derived from published risk flags

Evidence integrity

High

6 of 7 testing fields documented

Transaction transparency

High

4 of 5 commercial fields documented

Change activity

None tracked

0 change events tracked

Research Incomplete

Research coverage for this vendor is 89%. Our research on Biorbyt remains incomplete — what we have verified so far is published below, and research is continuing.

Still to research:

Registration jurisdiction researched (state_of_registration)
Payment methods reviewed (accepted_payment_methods)
Public summary reviewed

Overview#

Biorbyt is a Cambridge, UK life-science reagents supplier founded in 2010/2011 (Queen's Award for Enterprise: International Trade, 2021), acquired by AVS Bio (Arlington Capital Partners) in September 2026. FIT is confirmed but should be scoped honestly: peptides are a real but minority line in a catalog dominated by antibodies, proteins, ELISA kits and small molecules — Biorbyt sells catalog peptides (notably antibody blocking peptides, HPLC-purified, with public per-SKU datasheets) and offers a custom peptide synthesis service. Its U.S. presence is genuine: vendor-issued datasheets are published under 'Biorbyt LLC' at 68 TW Alexander Drive, Research Triangle Park, Durham NC. The verification limit is registry access — the North Carolina SoS portal blocked text retrieval (HTTP 403), so the LLC's registration state, formation and registered agent are recorded Unknown rather than inferred from its address. Documentation practice is distributor-grade: public datasheets instead of lot-matched CoAs, no independent lab named and no verification portal; commercial terms, by contrast, are fully published, including a detailed cancellations/returns regime (§14: written-authorization returns, up-to-25% restocking fees, non-cancellable custom/cold-chain orders). All defined regulatory searches (FDA warning letters, recalls, import alerts, FTC, state AG, civil litigation, criminal/injunctive) returned No Record Found in the defined search, and no customer-complaint pattern was found (search noise from similarly named companies excluded). Only minor evidence inconsistencies exist (founding year 2010 vs 2011; legacy 415 phone codes; HQ presentation). No serious (High/Critical) findings.

Company Identity#

Vendor Brand NameBiorbyt

HighSource: Biorbyt homepage

Primary Website Domainbiorbyt.com

ModerateSource: Biorbyt — official website (intake domain confirmation)

Legal Entity NameBiorbyt LLC (U.S. operation) and Biorbyt Ltd (UK parent)

HighSource: Biorbyt — Product Datasheet orb1236007 (SIRT1 Peptide), footer: Biorbyt LLC / Biorbyt Ltd. with both addresses

State of RegistrationNot independently verified

UnknownSource: North Carolina Secretary of State — Business Registration search portal (access blocked to text retrieval, HTTP 403; no record retrieved)

Entity StatusActive — trading continuously; acquired by AVS Bio in September 2026 and continuing to operate under its existing brand and leadership

ModerateSource: Pulse2 — AVS Bio acquires Biorbyt (Sep 24, 2026)

Incorporation / Formation Date2011 (company-stated founding year; LinkedIn lists 2010)

ModerateSource: Cambridge Network — Biorbyt receives Queen's Award for Enterprise (company statement: founded 2011)

Named Principals / ManagersTillmann Ziegert — CEO (per company statements). Owner since September 2026: AVS Bio, a portfolio company of Arlington Capital Partners

ModerateSource: Cambridge Network — Queen's Award article quoting CEO Tillmann Ziegert

Registered AgentNot independently verified

UnknownSource: North Carolina Secretary of State — Business Registration search portal (no record retrieved)

Operating AddressUK HQ: 7 Signet Court, Swann Road, Cambridge CB5 8LA, United Kingdom. U.S. office: 68 TW Alexander Drive, Research Triangle Park, Durham, NC 27713-2847, United States

HighSource: Biorbyt homepage — contact block (Cambridge UK and Durham NC addresses)

Address ConsistencyConsistent — the Cambridge and Durham addresses are identical across the website and product datasheets. Two legacy artifacts are noted: the U.S. phone (+1 415 906-5211) retains a San Francisco area code although the U.S. office is now in North Carolina (LinkedIn lists HQ as Durham, NC), and the company presents Cambridge as HQ while LinkedIn lists Durham

ModerateSource: Biorbyt homepage and datasheets (addresses); LinkedIn profile (HQ listed as Durham, NC)

Domain and Digital Identity#

Domain Registration Date2009-09-09

HighSource: Verisign RDAP — biorbyt.com

Domain Ownership / Registrar Change HistoryCurrent registrar 123-Reg Limited; RDAP record last changed 2026-09-10 — the same month as the AVS Bio acquisition (RDAP does not state a reason for the change). Earlier registrar/ownership history was not retrieved in this pass

ModerateSource: Verisign RDAP — biorbyt.com

Website ContinuityContinuity supported — domain registered 2009-09-09; company trading since 2010/2011 (Queen's Award for Enterprise: International Trade in 2021) and currently operating a large live catalog (1M+ SKUs claimed) with 2026 content and an intact brand post-acquisition

HighSource: Verisign RDAP — biorbyt.com; Cambridge Network Queen's Award article (2021)

Contact Channel IntegrityPublished corporate channels: info@biorbyt.com / support@biorbyt.com; UK +44 (0)1223 859353; US +1 (415) 906-5211; fax +1 (415) 651-8558; full office addresses on the site and on product datasheets — mutually consistent

HighSource: Biorbyt homepage — contact block

Regulatory and Legal History#

FDA Warning Letter HistoryNo Record Found in the defined search

HighSource: Defined web search of FDA warning letters — no letter naming Biorbyt

FDA Recall / Safety Action HistoryNo Record Found in the defined search

ModerateSource: Defined web search of FDA recalls — no recall naming Biorbyt

FDA Import Alert / Detention ExposureNo Record Found in the defined search

ModerateSource: Defined web search of FDA import alerts — no alert naming Biorbyt

FTC Enforcement HistoryNo Record Found in the defined search

HighSource: Defined web search of FTC enforcement — no action naming Biorbyt

State Regulatory / Attorney General ActionsNo Record Found in the defined search

ModerateSource: Defined web search of state AG/regulatory actions — none naming Biorbyt

Relevant Civil LitigationNo Record Found in the defined search

ModerateSource: Defined web search of litigation involving Biorbyt — none found

Criminal / Injunctive ProceedingsNo Record Found in the defined search

ModerateSource: Defined web search of criminal/injunctive proceedings — none naming Biorbyt

Testing and COA Evidence#

Public COA AvailabilityProduct datasheets are publicly downloadable for every catalog item, including peptide products (stating form, purification — e.g., 'Purified using HPLC' — storage and expiry). Batch-specific Certificates of Analysis are not published in a public lot library found in this pass

ModerateSource: Biorbyt — Product Datasheet orb1236007 (SIRT1 Peptide)

Batch / Lot SpecificityLimited — the documents inspected are catalog-level datasheets (per SKU: catalog number, form/appearance, storage, 12-months-from-receipt expiry convention) rather than lot-specific test reports

ModerateSource: Biorbyt — Product Datasheet orb1459986 (CLPX blocking peptide)

Independent Laboratory IdentityNot independently verified

UnknownSource: Biorbyt homepage — sourcing/distribution model, no lab named

COA Verification StatusDatasheet-based documentation only; no independent CoA verification portal was found

ModerateSource: Biorbyt — Product datasheets (documentation model)

Test RecencyNo dated batch test reports were inspected; current datasheets (crawled within the last ~6 months) state a standard 12-month expiry from date of receipt for peptide products

LowSource: Biorbyt — Product Datasheet orb1236007 (expiry: 12 months from date of receipt)

Testing CoveragePeptide products state HPLC purification on their datasheets (e.g., antibody blocking peptides 'Purified using HPLC'); beyond datasheet specifications, published QC detail is limited. A custom peptide synthesis service is offered (per the September 2026 AVS Bio acquisition release, which lists peptide synthesis among Biorbyt's services)

ModerateSource: Biorbyt — Product Datasheet orb1512846 (HPLC purification)

Evidence ConsistencyMostly consistent — entity names (Biorbyt Ltd / Biorbyt LLC), both office addresses, emails and phones agree across the website and product datasheets. Minor inconsistencies recorded: founding year 2011 (company) vs 2010 (LinkedIn); a legacy San Francisco (415) phone/fax pairing retained alongside the North Carolina U.S. office; HQ presented as Cambridge (company) vs Durham, NC (LinkedIn)

ModerateSource: Biorbyt homepage/datasheets vs LinkedIn company profile

Payment, Refund and Shipping#

Accepted Payment MethodsNot independently verified

UnknownSource: Biorbyt — Terms and Conditions of Sale (payment instruments not enumerated in sections reviewed)

Refund / Return PolicyDocumented in the Terms & Conditions of Sale (§14 Cancellation and Returns): cancellation is possible only before dispatch and only if accepted in writing — free within 24 hours of order confirmation if no processing has begun, otherwise a restocking/administration fee of up to 25% plus third-party costs may apply. Custom, made-to-order, cold-chain, hazardous and specially procured products are non-cancellable once processing begins. No returns are accepted without prior written authorization; shipping/handling charges are non-refundable except where the return is due to Biorbyt's accepted error or a valid warranty claim

HighSource: Biorbyt — Terms and Conditions of Sale, §14 Cancellation and Returns

Shipping & Fulfillment RepresentationsShips internationally from its UK/US/China offices and distributor network; peptide datasheets specify cold-chain handling (shipped at 4°C or stored at −20°C; 12-month expiry from receipt). Delivery and risk terms are governed by the published Terms & Conditions of Sale

ModerateSource: Biorbyt — Product Datasheet orb1512846 (storage/shipping conditions); homepage (offices and distributors)

Terms / Policy StabilityPublished, structured Terms & Conditions of Sale and a separate Website Terms of Use are live on biorbyt.com and internally cross-referenced (the Terms of Use expressly route product liability/returns to the Terms and Conditions of Sale). No version date was extracted in this pass

ModerateSource: Biorbyt — Website Terms of Use (cross-reference to Terms and Conditions of Sale)

Customer Complaint PatternNo Record Found in the defined search

ModerateSource: Defined web search for Biorbyt reviews/complaints — no pattern found (name-collision results excluded)

Material Changes#

No material changes recorded.

Sources#

North Carolina Secretary of State — Business Registration search portal (no record retrieved)Tier 1 · AuthoritativeSos Business SearchAuthoritative

Retrieved: October 20, 2026